| 1 |
35082055 | Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis. | 2022 Apr |
1 |
| 2 |
32916322 | The Importance of Complement Testing in Acquired Angioedema Related to Angiotensin-Converting Enzyme Inhibitors. | 2021 Feb |
1 |
| 3 |
33186235 | Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study. | 2021 Jun 1 |
2 |
| 4 |
33553408 | Recurrent Takotsubo cardiomyopathy triggered by emotionally stressful events: A case report. | 2021 Jan 26 |
1 |
| 5 |
34074111 | Perindopril: a long-term certainty in treating hypertension. | 2021 Spring |
2 |
| 6 |
34248634 | Effects of the Local Bone Renin-Angiotensin System on Titanium-Particle-Induced Periprosthetic Osteolysis. | 2021 |
1 |
| 7 |
34614428 | Short-term effect of angiotensin converting enzyme inhibitor on choroidal vascularity. | 2021 Dec |
1 |
| 8 |
34616396 | SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril). | 2021 |
1 |
| 9 |
32410885 | Efficacy and Safety of Perindopril in Patients with Essential Hypertension. | 2020 Mar |
1 |
| 10 |
33072254 | ACE inhibitor-induced small bowel angioedema, mimicking an acute abdomen. | 2020 Oct |
1 |
| 11 |
30535909 | A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC. | 2019 Mar |
2 |
| 12 |
30942616 | The Effect of Angiotensin-Converting Enzyme Gene Polymorphisms on the Clinical Efficacy of Perindopril Prescribed for Acute Myocardial Infarction in Chinese Han Patients. | 2019 May |
8 |
| 13 |
31578675 | A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril. | 2019 Dec |
2 |
| 14 |
29635787 | Effect of centrally acting angiotensin converting enzyme inhibitor on the exercise-induced increases in muscle sympathetic nerve activity. | 2018 Jun |
1 |
| 15 |
30573480 | Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study. | 2018 Dec 19 |
1 |
| 16 |
28840773 | Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells. | 2017 Dec |
2 |
| 17 |
28856537 | The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. | 2017 Aug |
1 |
| 18 |
26794937 | The advantages of combination therapy on hypertension: development of immediate release perindopril-indapamide tablet and assessment of bioequivalence studies. | 2016 Mar |
2 |
| 19 |
27021566 | Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model. | 2016 Mar 28 |
2 |
| 20 |
28002478 | The Effects of Rilmenidine and Perindopril on Arousal Blood Pressure during 24 Hour Recordings in SHR. | 2016 |
1 |
| 21 |
25590639 | Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine. | 2015 May |
3 |
| 22 |
25680080 | The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. | 2015 Apr 15 |
1 |
| 23 |
25980448 | A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. | 2015 Oct |
1 |
| 24 |
25985327 | RAS inhibitors' dose-dependent efficacy: myth or reality? | 2015 |
2 |
| 25 |
26075856 | [Combination treatment of hypertension in 2015]. | 2015 May |
1 |
| 26 |
26341621 | Perindopril/amlodipine (Prestalia(®)): a review in hypertension. | 2015 Oct |
1 |
| 27 |
24117346 | Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease. | 2014 Mar |
4 |
| 28 |
25012003 | Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: a randomized trial. | 2014 Aug |
1 |
| 29 |
25131919 | Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects. | 2014 Oct 20 |
1 |
| 30 |
25189490 | The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. | 2014 Oct 20 |
2 |
| 31 |
25518516 | [Principles of choice of an angiotensin-converting enzyme inhibitor: specific features of perindopril]. | 2014 |
2 |
| 32 |
25902655 | [Direct comparison of endothelial and metabolic effects of perindopril combination with indapamide retard or hydrochlorothiazide]. | 2014 |
1 |
| 33 |
23681954 | Twenty-four-hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed-dose combination. | 2013 Jul |
1 |
| 34 |
23711055 | [Perindopril in the treatment of hypertension and cardiovascular diseases: evolution continues with the orodispersible dosage form]. | 2013 Apr |
1 |
| 35 |
23879022 | [Changes of retinal neurons and Muller glial cells in patients with type II diabetes in treatment of diabetic retinopathy with angiotensin-converting enzyme inhibitor]. | 2013 May-Jun |
1 |
| 36 |
23933903 | Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. | 2013 Jul |
3 |
| 37 |
23952947 | [Effect of perindopril on the processes of subclinical inflammation in patients with arterial hypertension and type 2 diabetes mellitus]. | 2013 |
1 |
| 38 |
24285767 | Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease. | 2013 Nov |
1 |
| 39 |
21688035 | Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study. | 2012 Jan |
2 |
| 40 |
22619549 | Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. | 2012 |
1 |
| 41 |
22877321 | Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension. | 2012 Sep 1 |
3 |
| 42 |
21466773 | [Angiotensin converting enzyme inhibitor and calcium antagonist combination. Which place in patients with a stable coronary artery disease?]. | 2011 Jan-Feb |
1 |
| 43 |
21599567 | Perindopril for the treatment of hypertension. | 2011 Jul |
1 |
| 44 |
21857085 | Effects of angiotensin-converting enzyme inhibitors beyond lowering blood pressure--are they important for doctors? | 2011 |
2 |
| 45 |
19717156 | A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome? | 2010 Mar |
2 |
| 46 |
20491360 | Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend. | 2010 Mar-Apr |
2 |
| 47 |
20634797 | Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE". | 2010 Nov |
4 |
| 48 |
20681466 | [BRNO Register 2: post-myocardial infarction pharmacotherapy]. | 2010 Jun |
1 |
| 49 |
20712529 | Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit. | 2010 Aug |
1 |
| 50 |
21694942 | Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension. | 2010 |
2 |